Philip Morris International has been downgraded to a Hold rating due to its valuation reaching the high end of its historical range. The company's growth is primarily driven by its smoke-free product segment, which now accounts for 42% of net revenue, with strong performance in international markets. Expansion in the U.S., especially with IQOS and ZYN products, remains a key growth driver, though regulatory risks and competition continue to pose challenges. The company has a strong dividend track record with 17 consecutive years of growth, but the current 3.1% yield may be less attractive for income-focused investors.
Altria offers a 6.6% dividend yield with 60 consecutive raises, but its core cigarette business is shrinking, and its smoke-free product efforts are failing. The company faces falling cigarette volumes and declining market share in nicotine pouches, ...
Philip Morris International outperforms British American Tobacco in dividend growth, cash flow, and smoke-free product sales despite both facing a declining cigarette market. Philip Morris pays dividends in U.S. dollars with steady increases and has ...
